PDCD1 and autoimmune disease: Unlike immunosuppressive biologic therapies [tumor necrosis factor (TNF)-alpha inhibitors] used for the treatment of autoimmune disease, very few investigational protocols incorporating anti-PD-1 or anti-PD-L1 therapy require TB screening [5].